2m 2m 2m 2m 2m 2m 2m
Alkermes (ALKS)
NASDAQ
$48.99-$0.005 (-0.01%)
Price as of Jul 31, 2026 7:34 PM EDT- $8.1BMarket Cap
- 84.52%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Alkermes (ALKS)
$48.99-$0.005 (-0.01%)
ALKS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $48.99 | ||
Change | -$1.04 (-2.08%) | ||
Open | $49.63 | ||
High | $49.83 | ||
Low | $48.52 | ||
Previous Close | $50.03 | ||
Volume | 1,624,487 | ||
30-Day Average Volume | 1,787,526 | ||
1-Week Change | -7.37% | ||
1-Month Change | -6.50% | ||
1-Year Change | 84.52% | ||
3-Year Change | 67.32% | ||
5-Year Change | 89.37% | ||
Fundamentals | |||
Shares Outstanding | 164.8M | ||
Total Assets | $4.4B | ||
Market Cap | $8.1B | ||
Enterprise Value | $9.1B | ||
Period: QTR TTM FY | |||
Revenue | $411.7M | ||
Net Income | $501,000.00 | ||
Free Cash Flow | $137.0M | ||
EBIT | $5.5M | ||
EBITDA | $35.8M | ||
Net Working Capital | $860.8M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 253 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 4 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 59 | ||
Price/Operating Cash Flow | 56 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue